EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma

Erwin Gäbele, Isabella Gigante iD, Mirella Pastore iD, Antonio Cigliano, Grazia Galleri iD, Thea Bauer, Elena Pizzuto, Serena Mancarella iD, Martina Müller iD, Fabio Marra iD, Heiko Siegmund, Gianluigi Giannelli iD und 4 weitere

International Journal of Molecular Sciences · 18.09.2025 · 26 (18) · 9085

DOI: 10.3390/ijms26189085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.09.2025. Verfasst von Erwin Gäbele und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany. Hauptthemen laut MEDLINE: Trabectedin, Cholangiocarcinoma, Carbolines, Heterocyclic Compounds, 4 or More Rings. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association Against Cancer - AIRC, Italian Association Against Cancer (AIRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor. Due to its aggressive nature and resistance to conventional treatments, there is a pressing need to develop novel and more effective therapies for this deadly malignancy. Here, we explored the therapeutic potential of the DNA minor groove binders trabectedin (TRB) and lurbinectedin (LUR) for the treatment of iCCA using cell lines, spheroids, cancer-associated fibroblasts (CAFs), patient-derived tumor organoids (PDOs), and the chicken chorioallantoic membrane (CAM) in vivo model. TRB and, more substantially, LUR, significantly inhibited cell growth in iCCA cell lines, spheroids, CAFs, and PDOs at very low nanomolar concentrations. Specifically, the two drugs significantly reduced proliferation, triggered apoptosis, and caused DNA damage in iCCA cells. At the metabolic level, TRB and LUR decreased mitochondrial respiration and glycolysis. At the molecular level, the two compounds effectively downregulated the mammalian target of rapamycin complex 1 (mTORC1) and Hippo/YAP pathways and suppressed the expression of yes-associated protein 1 (YAP1), cellular myelocytomatosis oncogene (c-Myc), E2F transcription factor 1 (E2F1), Bromodomain-containing protein 4 (BRD4), TEA domain transcription factor 4 (TEAD4), and cluster of differentiation 7 (CD7) proto-oncogenes. Furthermore, LUR significantly restrained the in vivo growth of iCCA cells in the CAM model. Our data indicate that TRB and LUR possess strong anti-proliferative and pro-apoptotic activities and could represent promising therapeutic agents for the treatment of iCCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrabectedinCholangiocarcinomaCarbolinesHeterocyclic Compounds, 4 or More RingsBile Duct NeoplasmsAntineoplastic AgentsHumansAnimalsCell Line, TumorCell ProliferationApoptosisChick Embryo

Stichwörter der Autor:innen

DNA damage responseapoptosiscancer-associated fibroblasts (CAFs)innovative therapiesintrahepatic cholangiocarcinomalurbinectedinpatient-derived tumor organoids (PDOs)trabectedin

Substanzen

TrabectedinPM 01183CarbolinesHeterocyclic Compounds, 4 or More RingsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine I, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Internisten-Regensburg.de, Internal Medicine Group Practice, 93053 Regensburg, Germany.
  • National Institute of Gastroenterology, IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.
  • Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.
  • Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

ORCID-Profile: Isabella Gigante, Mirella Pastore, Grazia Galleri, Serena Mancarella, Martina Müller, Fabio Marra, Gianluigi Giannelli, Chiara Raggi

Förderung

  • Italian Association Against Cancer - AIRC
  • Italian Association Against Cancer (AIRC)

Zitieren

APA

Gäbele, E., Gigante, I., Pastore, M., Cigliano, A., Galleri, G., Bauer, T., Pizzuto, E., Mancarella, S., Müller, M., Marra, F., Siegmund, H., Giannelli, G., Evert, M., Raggi, C., Calvisi, D. F., & Steinmann, S. M. (2025). The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences, 26(18), 9085. https://doi.org/10.3390/ijms26189085

Vancouver

Gäbele E, Gigante I, Pastore M, Cigliano A, Galleri G, Bauer T, et al. The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences. 2025;26(18):9085. doi:10.3390/ijms26189085

BibTeX
@article{Gbele2025,
  author = {Gäbele, Erwin and Gigante, Isabella and Pastore, Mirella and Cigliano, Antonio and Galleri, Grazia and Bauer, Thea and Pizzuto, Elena and Mancarella, Serena and Müller, Martina and Marra, Fabio and Siegmund, Heiko and Giannelli, Gianluigi and Evert, Matthias and Raggi, Chiara and Calvisi, Diego F and Steinmann, Sara M},
  title = {The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic Cholangiocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {9085},
  doi = {10.3390/ijms26189085}
}
Kostenlos starten →